Among the top-scoring cells from AD samples, we observed significant upregulation of canonical DAM markers, including APOE, ACSL1, while top-scoring cells from normal controls showed downregulation of DAM markers such as C1QB and C1QC (Figure.S7c-e). This evidence concerns the gene APOE and Alzheimer disease.